Leave a comment and click here to sub for MS Equity Analysis and Swing Moves. Overview Trevena Inc. (Nasdaq: TRVN) is set to present tomorrow February 12 at 9:15 EST at the 21st Annual BIO CEO & … [Read more...] about TRVN to Present at BIO & CEO Conference
Articles
$REPH – Recro Pharma, PDUFA Swing Trade
Leave a comment and click here to sub for MS Equity Analysis and Swing Moves. Introduction Recro Pharma (NASDAQ: REPH) engages in the research and development of non-opioid therapeutics for the … [Read more...] about $REPH – Recro Pharma, PDUFA Swing Trade
Morning Update-Form 13G’s On Deck!
Leave a comment and click here to sub for MS Equity Analysis and Swing Moves. Good Morning! We hope you all are enjoying your early morning trading! Today, three companies we … [Read more...] about Morning Update-Form 13G’s On Deck!
2019 Should Be A Good Year For TRVN, But What’s Next?
Introduction Trevena Inc. (Nasdaq: TRVN) spiked 119% from the $.5 range to $1.19 on January 28th. The catalyst being positive regulatory updates from the FDA Type A meeting minutes. In a nut-shell the … [Read more...] about 2019 Should Be A Good Year For TRVN, But What’s Next?
GALT Director Sells 30K Shares
Leave a comment and click here to sub for MS Equity Analysis and Swing Moves. A form-4 just filed on 02/04/2019 by Galectin Therapeutics (Nasdaq: GALT) reports that GALT director … [Read more...] about GALT Director Sells 30K Shares
MS Identified Its Next Swing
Leave a comment and click here to sub for MS Equity Analysis and Swing Moves. Preface WOW. We are absolutely elated with the performance of our last swing move on SCYX. In case you missed it on … [Read more...] about MS Identified Its Next Swing